Oppenheimer & CO Inc Catabasis Pharmaceuticals, Inc. Transaction History

Oppenheimer & CO Inc

  • $6.43 Billion
  • Q1 2025

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
N/A
-61,500 Closed
0 $0
Q2 2021

Aug 03, 2021
SELL
N/A
-5,500 Reduced 8.21%
61,500 $130,000
Q1 2021

May 10, 2021
SELL
N/A
-3,200 Reduced 4.56%
67,000 $194,000
Q4 2020

Feb 11, 2021
SELL
N/A
-35,521 Reduced 33.6%
70,200 $150,000
Q3 2020

Nov 13, 2020
SELL
N/A
-1,740 Reduced 1.62%
105,721 $654,000
Q2 2020

Aug 11, 2020
SELL
N/A
-719 Reduced 0.66%
107,461 $691,000
Q1 2020

May 08, 2020
BUY
N/A
29,931 Added 38.25%
108,180 $449,000
Q4 2019

Feb 07, 2020
SELL
N/A
-1,600 Reduced 2.0%
78,249 $462,000
Q3 2019

Oct 31, 2019
BUY
N/A
11,143 Added 16.22%
79,849 $431,000
Q2 2019

Aug 09, 2019
SELL
N/A
-23,178 Reduced 25.23%
68,706 $554,000
Q1 2019

Apr 24, 2019
BUY
N/A
45,303 Added 97.26%
91,884 $727,000
Q4 2018

Jan 29, 2019
BUY
N/A
46,581 New
46,581 $203,000

About Catabasis Pharmaceuticals, Inc.

CATB Quotes by TradingView
  • Ticker CATB
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,948,800
  • Market Cap $657M
More about CATB
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email